Day 2 :
- Nursing practitioners
Session Introduction
Dirk Wackernage
Karolinska University Hospital, Stockholm, Sweden
Title: Swedish national guideline for prevention and treatment of neonatal hypoglycaemia in newborn infants with gestational age ≥35 weeks
Biography:
Dirk Wackernage is a neonatologist by heart, trying to improve treatment and outcome for our sick patients. Optimizing nutrition and growth in sick newborn term and preterm infants is my main research interest. One particular aspect is the postnatal glucose homeostasis following birth. In addition drug safety and patient safety is an other interest. He is an ultrasound enthusiast mainly of the newborn brain but even all other organ systems.
Abstract:
Aim: Postnatal hypoglycaemia in newborn infants remains an important clinical prob†lem where prolonged periods of hypoglycaemia are associated with poor neurode†velopmental outcome. The aim was to develop an evidenceâ€based national guideline with the purpose to optimise prevention, diagnosis and treatment of hypoglycaemia in newborn infants with a gestational age ≥35 + 0 weeks.
Methods: A PubMed searchâ€based literature review was used to find actual and ap†plicable evidence for all incorporated recommendations. The GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach was used for grading the evidence of the recommendations.
Results: Recommendations for the prevention of neonatal hypoglycaemia were extended and updated, focusing on promotion of breastfeeding as one prevention strategy. Oral dextrose gel as a novel supplemental therapy was incorporated in the treatment protocol. A new thresholdâ€based screening and treatment protocol pre†sented as a flow chart was developed.
- Behaviour Of Child-Growth & Development
Session Introduction
Alej-An Joyce Marie
University of Santo Tomas Hospital, Philippines
Title: Neurodevelopmental outcome of infants born to mothers with COVID-19 infection during pregnancy: A meta-analysis
Biography:
Alej-An Joyce Marie A. Gumpal-Te has done MD, RPh and is affiliated to University of Santo Tomas Hospital, Faculty of Medicine and Surgery, Philippines.
Abstract:
Methodology: This study utilized a meta-analysis design. Studies published up to September 30, 2022 were included in the analysis.
Data analysis: STATA MP Statistical Software, Version 13, College Station, TX: StataCorp LP was utilized for all statistical analyses. A p-value ≤ 0.05 was considered statistically significant. Since estimated heterogeneity is non-significant and not substantial, a fixed-effect model was utilized. Pooled risk ratio was utilized as the summary effect measure for the risk of neurodevelopmental delays and was estimated with their corresponding 95% confidence intervals. Heterogeneity was scrutinized using the following statistical tests: Q statistics test, I2 statistics and tau squared statistics. I2 values greater than 50% imply substantial heterogeneity, while a Q-statistics with a significant p-value denotes a statistically significant heterogeneity.
Results: Two studies with a total population of 7,848 patients met the eligibility criteria. Results indicated that all included studies have good quality of evidence in the areas of selection, comparability and exposure. Appraisal of the included studies in these areas of evaluation also showed that all studies were of good quality. The pooled risk of neurodevelopmental delays among infants born to COVID- 19 positive mother was 2.00% higher than those born from mothers who were negative for COVID-19 infection. However, this was not statistically significant. Graphical analysis of publication bias showed funnel symmetry, suggestive that publication bias was unlikely. This result was confirmed with formal statistical tests using Begg’s adjusted rank correlation test and Egger’s regression asymmetry test.
Conclusion: Although not statistically significant, infants born to mothers with COVID-19 infection during pregnancy have increased risk of neurodevelopmental delay. This may be attributed to the limited number of studies and articles available and in part because children born to women infected in the first wave of the pandemic are younger than two years of age. In addition, majority of developmental delay reflected developmental disorders of motor function or speech and language.